Clinical Trial

A Multicenter Cross-sectional Study on Tinnitus Subtypes and Risk Factors

Completed
View on ClinicalTrials.gov →
Summary
Tinnitus affects an estimated 10-15% of the global population and can substantially impair quality of life, yet clinically actionable approaches for subtype identification and risk stratification remain limited. This multicenter, cross-sectional observational study will use de-identified electronic health record (EHR) data from three otolaryngology specialty hospitals in China to address these gaps. All extracted data will be de-identified with direct identifiers removed, and privacy safeguards will be implemented in accordance with institutional policies and applicable regulations to protect patient confidentiality.
Trial Details
NCT Number NCT07383675
Lead Sponsor Shanghai Jiao Tong University School of Medicine
Collaborators: Chongqing Renpin ENT. Hospital, China, Nanjing Renpin ENT. Hospital, China, Chengdu Renpin ENT. Hospital, China
Conditions Tinnitus
Enrollment 3,345 participants
Start Date 2022-03-01
Primary Completion 2024-11-30 (estimated)
Study Completion 2026-01-16 (estimated)
Updated on ClinicalTrials.gov 2026-02-03